POST-TRANSLATIONAL MODIFICATIONS OF PROTEIN PHOSPHATASE 2A (PP2A) IN MIXED LINEAGE LEUKEMIA (MLL)
EHA Library, Yoana ARROYO, 266617
SINGLE-CELL RNA-SEQUENCING & GENOTYPING OF PATIENTS WITH WT1-SUBCLONAL AML TO ELUCIDATE CLONAL HETEROGENEITY
EHA Library, Julia Niggemeyer, 266632
COMPARATIVE ANALYSES OF LEUKEMIC BLAST PHENOTYPE AND MUTANT/WT EXPRESSION RATIO IN FLT3-ITD ACUTE MYELOID LEUKEMIAS
EHA Library, Dan Soare, 266633
DECITABINE VERSUS INTENSIVE CHEMOTHERAPY IN ELDERLY UNTREATED ACUTE MYELOID LEUKEMIA
EHA Library, Adolfo De La Fuente, 266648
SURVIVAL FROM ACUTE MYELOID LEUKEMIA HAS SINCE 1997 IMPROVED ONLY IN MALES AGED 50-75 YEARS - A SWEDISH POPULATION-BASED STUDY
EHA Library, Gunnar JULIUSSON, 266649
EFFICACY AND SAFETY EVALUATION OF DIFFERENT DOSES OF ANTHRACYCLINES IN THE INDUCTION THERAPY FOR NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
EHA Library, Xiaohui Hu, 266664
BASELINE SERUM LEVELS OF RECEPTORS FOR INTERLEUKIN-2 AND TUMOR NECROSIS FACTOR-Α PREDICT OVERALL SURVIVAL IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
EHA Library, Tomas Kupsa, 266665
RESULTS OF PIVOTAL PHASE 2 CLINICAL TRIAL OF TAGRAXOFUSP (SL-401) IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)
EHA Library, Naveen Pemmaraju, 266680
EXPLORATORY ANALYSIS OF OUTCOMES WITH SEQUENTIAL FLT3-INHIBITOR (FLT3I) BASED THERAPIES IN RELAPSED FLT3-MUTATED AML PATIENTS (PTS)
EHA Library, Masnour Alfayez, 266681
LYMPHOMA ASSOCIATED HEMOPHAGOCYTIC SYNDROME: A SINGLE-CENTER EXPERIENCE.
EHA Library, Javier Alberto Rojas Martínez, 266697
UTILITY OF BONE MARROW BIOPSY IN POSITRON EMISSION TOMOGRAPHY-STAGED PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Mark Grech, 266698
PROGNOSTIC SIGNIFICANCE OF SAMHD1 EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
EHA Library, Ioanna Xagoraris, 266699
INTERIM UPDATE FROM A MULTI-CENTER STUDY OF PRALATREXATE IN ASIAN PATIENTS WITH RELAPSED OR REFRACTORY(R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL)
EHA Library, Ming-Chung Wang, 266713
ADULT T-CELL LEUKEMIA/LYMPHOMA : EPIDEMIOLOGY, CLINICAL FEATURES AND OUTCOME OF A CARIBBEAN COHORT FROM GUADELOUPE
EHA Library, Philippe HELIAS, 266714
ADULT ONSET HEREDITARY THROMBOTIC THROMBOCYTOPENIC PURPURA WITH A NOVEL ADAMTS13 MUTATION
EHA Library, Julian Freue, 266715
THE RELATIONSHIP BETWEEN THE PRETREATMENT PNH CLONE SIZE AND CLINICAL COURSE IN PATIENTS WITH BONE MARROW FAILURE SYNDROMES: INTERIM ANALYSIS OF JAPANESE MULTICENTER PROSPECTIVE STUDY
EHA Library, Yasutaka Ueda, 266732
LATE ONSET NEUTROPENIA ASSOCIATED WITH RITUXIMAB. FREQUENCY AND RISK FACTORS IN A COHORT OF PATIENTS WITH NON HODGKIN LYMPHOMA AT INSTITUTO NACIONAL DE CANCEROLOGÍA MÉXICO.
EHA Library, Myrna Candelaria, 266733
NO CHANGE IN THE EFFECTIVENESS OF IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH PNH AND AA RECEIVING CONCOMITANT ECULIZUMAB
EHA Library, Anita Hill, 266734
HIGH-THROUGHPUT Β-CELL IMMUNOPROFILING AT DIAGNOSIS AND RELAPSE OFFERS FURTHER EVIDENCE OF FUNCTIONAL SELECTION THROUGHOUT THE NATURAL HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Anna Vardi, 266748
INHERITED DNA REPAIR AND CELL CYCLE GENE DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Jennifer Brown, 266749
GENOMIC ARRAYS IDENTIFY HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA WITH GENOMIC COMPLEXITY: A MULTI-CENTER STUDY
EHA Library, Alexander Leeksma, 266750
SPATIAL HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKAEMIA ANALYSED BY WHOLE-GENOME/EXOME SEQUENCING AT DIAGNOSIS
EHA Library, Ferran Nadeu, 266764
PRELIMINARY RESULTS OF A PHASE 1B/2 DOSE-ESCALATION AND COHORT-EXPANSION STUDY OF THE NONCOVALENT, REVERSIBLE BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), VECABRUTINIB, IN B-CELL MALIGNANCIES
EHA Library, John Allan, 266765
SECOND CANCER INCIDENCE IN CLL PATIENTS RECEIVING BTK INHIBITORS
EHA Library, David Bond, 266766
PATIENT-BASED PROSPECTIVE REAL WORLD DATA ANALYSIS SHOWS THAT THE DURATION OF TREATMENT INTERRUPTIONS WITH SUBSEQUENT RESUMPTION OF IDELALISIB THERAPY CAN VARY FROM DAYS TO MONTHS
EHA Library, Manuela Hoechstetter, 266780
SURVIVAL DISPARATIES IN HAIRY CELL LEUKEMIA ACROSS EUROPE: RESULTS OF RARECARENET--A POPULATION-BASED STUDY
EHA Library, Avinash Dinmohamed, 266781
VENETOCLAX FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A RETROSPECTIVE CHART REVIEW OF SAFETY AND EFFICACY FROM PRE-APPROVAL ACCESS (PAA) PROGRAMS IN THE EUROPEAN UNION
EHA Library, Anna Schuh, 266782
TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA PATIENTS HARBORING ATYPICAL BCR-ABL1 TRANSCRIPTS
EHA Library, Matteo Dragani, 266796
FOLLOW-UP OF LOWER DOSE DASATINIB 50MG DAILY AS FRONTLINE THERAPY IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML-CP)
EHA Library, Kiran Naqvi, 266797
DOSING PATTERNS OF DASATINIB AND NILOTINIB USE IN SIMPLICITY, AN OBSERVATIONAL STUDY IN CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS (PTS) IN ROUTINE CLINICAL PRACTICE
EHA Library, C Gambacorti, 266798
TIME TO HEALTH-RELATED QUALITY OF LIFE IMPROVEMENT IN THE PHASE 3 BFORE TRIAL: FIRST-LINE BOSUTINIB VS IMATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA
EHA Library, Tim H Brümmendorf, 266812
INNOVATIVE DIAGNOSTIC APPROACH FOR RARE ANEMIA
EHA Library, Valeria Rizzuto, 266813
ASSESSING THE EMA BINDING TEST AND OSMOTIC GRADIENT EKTACYTOMETRY IN THE DIAGNOSIS OF HEREDITARY SPHEROCYTOSIS DEFINED BY THE PRESENCE OF UNDERLYING DIAGNOSTIC MUTATIONS
EHA Library, Andreas GLENTHØJ, 266814
CD22 CAR T-CELL THERAPY IN 34 REFRACTORY OR RELAPSED B ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
EHA Library, Jing PAN, 266828
UPDATED RESULTS FROM PHASE I TRIALS ASSESSING A NKG2D CAR T-CELL APPROACH IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME PATIENTS
EHA Library, David Sallman, 266829
SEQUENTIAL CD19- AND CD22-DIRECTED CAR-T CELL THERAPIES IN 11 REFRACTORY OR RELAPSED B-ALL CHILDREN PATIENTS
EHA Library, Jing PAN, 266830
SF3B1 KNOCKDOWN AT EARLY ERYTHROPOIESIS INDUCED CELL APOPTOSIS BY USING A TET-ON LENTIVIRAL VECTOR
EHA Library, Yumin Huang, 266845
CHARACTERIZING THE ETIOLOGY OF PEDIATRIC ACUTE MYELOID LEUKEMIA BY STUDYING MUTATION ACCUMULATION IN NORMAL HEMATOPOIESIS
EHA Library, Arianne Brandsma, 266846
DEFINING THE ROLE OF E-CADHERIN DURING HEALTHY AND MALIGNANT HEMATOPOIESIS
EHA Library, Rosa Krimpenfort, 266847
NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: LONG TERM RESULTS OF MULTI-CENTER EXPERIENCE IN TURKEY
EHA Library, Burhan Ferhanoglu, 266862
GRAFT SOURCE AND PRE-TRANSPLANT DISEASE STATUS ARE THE MAIN VARIABLES AFFECTING THE OUTCOME OF T CELL-REPLETE HAPLOIDENTICAL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR HODGKIN LYMPHOMA
EHA Library, Jacopo Mariotti, 266863
EZH2 GAIN-OF-FUNCTION MUTATIONS ARE NOT ASSOCIATED WITH MORE FAVORABLE PROGNOSIS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: A PRELIMINARY ANALYSIS ON 590 PATIENTS
EHA Library, Jessica Okosun, 266864
CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS OF 33 PATIENTS WITH SEZARY SYNDROME AT MOFFITT CANCER CENTER: A SINGLE-INSTITUTION COHORT
EHA Library, Yumeng Zhang, 266878
POST HOC ANALYSIS OF THE AUGMENT PHASE III RANDOMIZED STUDY OF LENALIDOMIDE PLUS RITUXIMAB (R2) VS RITUXIMAB/PLACEBO IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA
EHA Library, Catherine Thieblemont, 266879
CONSOLIDATION THERAPY USING 90Y-IBRITUMOMAB TIUXETAN AFTER BENDAMUSTINE AND RITUXIMAB IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA; A MULTICENTER, PHASE II STUDY (BRIZ2012)
EHA Library, Hideki Tsujimura, 266880
EVALUATION OF THE IMMUNITY TO MEASLES, MUMPS AND RUBELLA IN ADULT PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Koji Kawamura, 266894
LACTATE CLEARANCE AS A SURVIVAL PREDICTOR IN PATIENTS WITH HEMATOLOGIC DISEASES WITH SEPTIC SHOCK
EHA Library, Iurii Osipov, 266895
A PRACTICAL UPDATE ON THE EPIDEMIOLOGY AND RISK FACTORS FOR THE EMERGENCE AND MORTALITY OF BLOODSTREAM INFECTIONS IN 3014 PATIENTS WITH HEMATOLOGICAL MALIGNANCY RECEIVING CHEMOTHERAPY
EHA Library, zhen Chen, 266896
OSTEOGENESIS IMPERFECTA : A NEW UNRECOGNIZED ETIOLOGY FOR FUNCTIONAL IRON DEFICIENCY
EHA Library, Iman Ragab, 266910
MULTIFACTORIAL HEPCIDIN SUPPRESSION IN BETA-THALASSEMIA CARRIERS WITH IRON OVERLOAD
EHA Library, Fabiana Busti, 266911
IRON IN THE HUMAN HEARTS: DISTRIBUTION AND ASSOCIATION WITH R2* VALUES BY CMR
EHA Library, Antonella Meloni, 266912
A NOVEL NPM-ALK-DRIVEN MODEL OF CD30+ T-CELL LYMPHOMA
EHA Library, Khalid Shoumariyeh, 266926
THE NOVEL BISPECIFIC CD47-CD19 ANTIBODY TG-1801 POTENTIATES THE ACTIVITY OF UBLITUXIMAB-UMBRALISIB (U2) DRUG COMBINATION IN PRECLINICAL MODELS OF B-NHL
EHA Library, Marcelo L Ribeiro, 266927
PI3K-INHIBITION INCREASES APOPTOTIC PRIMING IN T-CELL LYMPHOMAS AND SYNERGIZES WITH BH3 MIMETICS.
EHA Library, Gerrit Nothnick, 266928
IDENTIFICATION AND TARGETING OF MOLECULAR SIGNATURES OF HYPOMETHYLATING AGENT RESISTANCE IN MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA
EHA Library, Yue Wei, 266942
IMPLEMENTATION OF FUNCTIONAL ASSAYS TO CHARACTERIZE AND DETERMINE THE CLINICAL IMPACT OF RUNX1 VARIANTS OF UNCERTAIN SIGNIFICANCE IN SPORADIC DISEASES AS WELL AS IN THE CONTEXT OF FPDMM
EHA Library, Tim Ripperger, 266943
PRO-NECROPTOTIC RIPK3 AS A STAGE-DEPENDENT MARKER IN THE BONE MARROW OF PATIENTS WITH MDS AND CMML
EHA Library, Veronika Dill, 266944
CLINICAL SIGNIFICANCE OF KIR GENOTYPE IN JAPANESE PATIENTS WITH MYELODYSPLASTIC SYNDROME
EHA Library, Norina Tanaka, 266958
PREDICTING SURVIVAL AND TRANSFORMATION IN YOUNG AND MIDDLE-AGED PATIENTS WITH MYELODYSPLASTIC SYNDROME
EHA Library, Natalia Klimkovich, 266959
ARE MYELODYSPLASTIC SYNDROMES WITH ISOLATED 20Q DELETION A DIFFERENT CLINICAL-BIOLOGICAL ENTITY?
EHA Library, Alessia Campagna, 266960
DYSREGULATED MICRORNA EXPRESSION IN CIRCULATING PLASMA CELLS IN MULTIPLE MYELOMA
EHA Library, Jana Gregorová, 266976
LONG NON-CODING RNA NEAT1 TARGETING TRIGGERS ANTI-TUMOR ACTIVITY AND RESULTS IN CHEMO-SENSITIZING EFFECT IN MULTIPLE MYELOMA CELLS
EHA Library, Elisa TAIANA, 266977
BIDIRECTIONAL MITOCHONDRIAL TRANSFER BETWEEN MYELOMA CELLS AND BONE MARROW STROMAL CELLS CONTRIBUTES TO THE CHEMORESISTANCE OF MYELOMA CELLS
EHA Library, Zsolt Matula, 266978
UPDATED SAFETY AND EFFICACY FROM A PHASE 2 STUDY OF VENETOCLAX PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
EHA Library, Luciano J. Costa, 266992
LENALIDOMIDE MAINTENANCE POSITIVELY IMPACTS OUTCOMES IN MULTIPLE MYELOMA WITHOUT NEGATIVE IMPACTS IN RELAPSE: AN ANALYSIS OF REAL WORLD DATA FROM THE MYELOMA CANADA RESEARCH NETWORK NATIONAL DATABASE
EHA Library, Christopher Venner, 266993
ASSESSMENT OF THE BURDEN OF DISEASE IN TERMS OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MULTIPLE MYELOMA NOT ELIGIBLE FOR ASCT IN SPAIN: INTERIM ANALYSIS OF QOLMMBUS STUDY
EHA Library, Javier De La Rubia, 267008
CONSOLIDATION WITH A SHORT COURSE OF DARATUMUMAB CAN SIGNIFICANTLY IMPROVE COMPLETE RESPONSE RATES IN PATIENTS WITH AL AMYLOIDOSIS OR LCDD
EHA Library, Efstathios Kastritis, 267009
TWICE WEEKLY CARFILZOMIB IS AN ACCEPTED TREATMENT BY PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY: INTERIM RESULTS OF THE CARO STUDY
EHA Library, Wolfgang Knauf, 267024
PROGNOSTIC SIGNIFICANCE OF CD56 EXPRESSION ON BONE MARROW PLASMA CELLS OF NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS.
EHA Library, Giulia Rivoli, 267025
NEXT-GENERATION SEQUENCING STUDY OF V(D)J REARRANGEMENTS ON NON-CR PATIENTS SHOWING MRD NEGATIVITY BY NEXT-GENERATION FLOW
EHA Library, Sung Min KIM, 267040
THE CRAB SCORE: A SIMPLE PROGNOSTIC TOOL IN MULTIPLE MYELOMA
EHA Library, Helena Bean, 267041
ENHANCED SUPPORT OF MYELOFIBROSIS STEM CELLS IN NEXT GENERATION HUMANIZED MICE
EHA Library, Veronika Lysenko, 267056
FAVORABLE OVERALL SURVIVAL OF IMETELSTAT-TREATED RELAPSED/REFRACTORY MYELOFIBROSIS PATIENTS COMPARED WITH CLOSELY MATCHED REAL WORLD DATA
EHA Library, Andrew Kuykendall, 267073
MAINTENANCE OF RESPONSE IN LONG-TERM TREATMENT WITH ROPEGINTERFERON ALFA-2B (BESREMI®) VS. HYDROXYUREA IN POLYCYTHEMIA VERA PATIENTS (PROUD/CONTINUATION-PV PHASE III TRIALS)
EHA Library, Heinz Gisslinger, 267074
CURRENT PRACTICE IN THE MANAGEMENT OF ESSENTIAL THROMBOCYTEMIA AND POLYCYTHEMIA VERA: A SURVEY FROM THE FRENCH INTERGROUP OF MYELOPROLIFERATIVE NEOPLASMS (FIM) AMONG 120 HEMATOLOGISTS AND INTERNISTS
EHA Library, Guillemette FOUQUET, 267089
ULTRASONOGRAPHY VS RM FOR SPLEEN VOLUME EVALUATION IN MYELOPROLIFERATIVE NEOPLASMS: WHAT YOU NEED TO KNOW.
EHA Library, Novella Pugliese, 267090
TH1 CYTOKINE IFN-GAMMA+874T/A AND TNF-ALPHA-857C/T POLYMORPHISMS AFFECT THROMBOCYTOPENIA IN CHRONIC IMMUNE THROMBOCYTOPENIA (CITP)
EHA Library, Kana Souma, 267106
BERBERINE MAY CORRECT GUT MICROBIOTA-INDUCED CORTICOSTEROID RESISTANCE AND MESENCHYMAL STEM CELL DYSFUNCTION IN IMMUNE THROMBOCYTOPENIA BY REGULATING GUT MICROBIOTA STRUCTURE
EHA Library, Yanan Wang, 267107
APREPITANT AS ADJUNCT FOR THE MANAGEMENT OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS WITH HEMATOLOGIC MALIGNANCY UNDERGOING HIGHLY EMETOGENIC CHEMOTHERAPY: A META-ANALYSIS
EHA Library, Feroni Pella Panjaitan, 267123
INCREASED VOC FREQUENCY ASSOCIATED WITH REDUCED HRQOL AMONG PATIENTS WITH SCD
EHA Library, Miranda Bailey, 267124
CENTRAL PHYSIOLOGIC MECHANISMS WHICH AUGMENT OXYGEN RELEASE (BOHR EFFECT AND 2,3-DPG BINDING) ARE PRESERVED IN THE PRESENCE OF VOXELOTOR AT THE THERAPEUTIC TARGET OF 30% HB MODIFICATION
EHA Library, Mira Pochron, 267139
THE OXYGENSCAN: A COMPREHENSIBLE FUNCTIONAL RED BLOOD CELL TEST TO MONITOR TREATMENT EFFICACY IN PATIENTS WITH SICKLE CELL DISEASE
EHA Library, Minke Rab, 267140
SAFETY OF HEMATOPOIETIC STEM CELL DONATION. RETROSPECTIVE ANALYSIS OF EARLY POST DONATION FOLLOW UP IN VOLUNTARY DONORS REGISTERED IN DKMS FOUNDATION DONOR CENTER, POLAND
EHA Library, Tigran Torosian, 267155
A COMPARISON OF POST ALLOGENEIC STEM CELL TRANSPLANT CHIMERISM ANALYSIS METHODS: HIGH THROUGHPUT SNP GENOTYPING ANALYSED BY MALDI-TOF MASS SPECTROMETRY VS. SHORT TANDEM REPEAT (STR) MARKER ANALYSIS.
EHA Library, Kerry Wall, 267156
STUDY OF IMMUNE HEMOLYTIC DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Jianyun Liao, 267172
BRUTON TYROSINE KINASE INHIBITOR IS AN EFFECTIVE STEROID-SPARING AGENT IN CHRONIC GRAFT-VERSUS-HOST DISEASE
EHA Library, Osman Ilhan, 267173
HEART DISEASE AND PANCREATIC IRON IN THALASSEMIA MAJOR
EHA Library, Antonella Meloni, 267189
Β0 VS. NON-Β0 GENOTYPE: DIFFERENCES IN TDT PATIENTS
EHA Library, Antonella Meloni, 267190
FIBRINOLYSIS IN PATIENTS WITH CHEMOTHERAPY INDUCED THROMBOCYTOPENIA AND THE EFFECT OF PLATELET TRANSFUSION.
EHA Library, Floor Heubel-Moenen, 267205
RETROSPECTIVE ANALYSIS OF HEMOGLOBIN LEVEL IN 500 TRANSFUSION EVENTS AS A STUDY MODEL FOR THE EVALUATION OF TRANSFUSION APPROPRIATENESS
EHA Library, Roberto Crocchiolo, 267206
PHF6 LOSS DRIVES IL7R ONCOGENE ADDICTION IN TLX1 DRIVEN T-ALL
EHA Library, Siebe Loontiens, 267221
INACTIVATION OF SH2B3 THROUGH CN-LOH 12Q IS UNIQUELY ASSOCIATED WITH B-CELL PRECURSOR ALL WITH IAMP21 OR OTHER CHROMOSOME 21 GAIN.
EHA Library, Paul Sinclair, 267222
INTENSIVE PAEDIATRIC THERAPY IS AS DELIVERABLE IN ADOLESCENTS AND YOUNG ADULTS AS CHILDREN WITH ALL - PRELIMINARY RESULTS OF THE AUSTRALASIAN LEUKAEMIA AND LYMPHOMA GROUP (ALLG) ALL06 STUDY
EHA Library, Matthew GREENWOOD, 267239
CAR-T CELL THERAPY BRIDGING TO ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION LED TO SUPERIOR SURVIVAL FOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS OUT OF REMISSION
EHA Library, Xiaohui Hu, 267240
TIME FROM RANDOMIZATION TO FIRST SUBSEQUENT INDUCTION/SALVAGE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH INOTUZUMAB OZOGAMICIN IN THE PHASE 3 INO-VATE TRIAL
EHA Library, Elias Jabbour, 267255
FEASIBLE OUTCOME OF BLINATUMOMAB FOLLOWED BY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR ADULTS WITH RELAPSED OR REFRACTORY PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Jae-Ho Yoon, 267256
ACUTE MYELOID LEUKEMIA CELLS ARE DEPENDENT ON S100A4 FOR GROWTH AND SURVIVAL
EHA Library, Bader Alanazi, 267271
AT1413 ANTIBODY DERIVED FROM A CURED AML PATIENT RECOGNIZES A UNIQUE CD43 EPITOPE SHARED BY AML, MDS AND MELANOMA AND HAS IN VIVO ACTIVITY AS UNMODIFIED ANTIBODY AND AS BISPECIFIC T CELL ENGAGER
EHA Library, Greta de Jong, 267272
CHARACTERIZATION OF A NOVEL, POTENT SMALL MOLECULE MDM2 ANTAGONIST WHICH ACTIVATES WILD-TYPE P53 AND INDUCES APOPTOSIS IN AML
EHA Library, Nicola Ferrari, 267289
ABNORMAL DNA METHYLATION MODIFIES HOX GENES EXPRESSION IN BONE MARROW MESENCHYMAL STROMAL CELLS OF MYELODYSPLASIAS AND DE NOVO ACUTE MYELOID LEUKEMIAS
EHA Library, Benjamin Roux, 267290

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings